The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $137.74

Today's change+1.43 +1.05%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $137.74

Today's change+1.43 +1.05%
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.

Celgene Corp Hits New 52-week High

Celgene Corp closed up Friday by (U.S.)$1.43 or 1.05% to (U.S.)$137.74 and setting a new 52-week high. Over the last five days, shares have gained 2.36% and 19.00% year to date. Shares have outperformed the S&P 500 by 13.99% during the last year.

Key company metrics

  • Open(U.S.) $136.23
  • Previous close(U.S.) $136.31
  • High(U.S.) $138.17
  • Low(U.S.) $135.72
  • Bid / Ask(U.S.) $138.00 / (U.S.) $138.40
  • YTD % change+19.00%
  • Volume3,651,449
  • Average volume (10-day)3,126,024
  • Average volume (1-month)4,352,545
  • Average volume (3-month)3,740,916
  • 52-week range(U.S.) $96.93 to (U.S.) $138.17
  • Beta1.90
  • Trailing P/E51.88×
  • P/E 1 year forward18.72×
  • Forward PEG0.90×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.65
Updated July 21 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,9602,9812,9832,754
Total other revenue--------
Total revenue2,9602,9812,9832,754
Gross profit2,8472,8672,8752,643
Total cost of revenue113114108111
Total operating expense1,8522,3522,6171,963
Selling / general / administrative620685698732
Research & development9951,1351,654949
Depreciation / amortization8210587175
Interest expense (income), net operating--------
Unusual expense (income)4231471-4
Other operating expenses, total--------
Operating income1,108628366792
Interest income (expense), net non-operating-136-136-137-136
Gain (loss) on sale of assets--------
Other--------
Income before tax1,025499257695
Income after tax941429171598
Income tax, total84708597
Net income941429171598
Total adjustments to net income--------
Net income before extra. items941429171598
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items941429171598
Inc. avail. to common incl. extra. items941429171598
Diluted net income941429171598
Dilution adjustment--------
Diluted weighted average shares811802802802
Diluted EPS excluding extraordinary itemsvalue per share1.160.530.210.75
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.210.870.270.74